Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P04150: Variant p.Ile747Met

Glucocorticoid receptor
Gene: NR3C1
Feedback?
Variant information Variant position: help 747 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Isoleucine (I) to Methionine (M) at position 747 (I747M, p.Ile747Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In GCCR; alters interaction with NCOA2 and strongly reduces transcription activation; acts as a dominant negative mutant. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 747 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 777 The length of the canonical sequence.
Location on the sequence: help EVVENLLNYCFQTFLDKTMS I EFPEMLAEIITNQIPKYSNG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         EVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNG

Mouse                         DVVENLLSYCFQTFLDKSMSIEFPEMLAEIITNQIPKYSNG

Rat                           EVVENLLTYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNG

Pig                           DVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQLPKYSSG

Rabbit                        EVVENLLHYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNG

Xenopus laevis                EVAENLLAFCFLSFLDKSMSIEFPDMLSEIISNQIPKYSSG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 777 Glucocorticoid receptor
Domain 524 – 758 NR LBD
Region 485 – 777 Interaction with CLOCK
Alternative sequence 728 – 777 VVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK -> NVMWLKPESTSHTLI. In isoform Beta, isoform Beta-B, isoform Beta-2 and isoform GR-A beta.



Literature citations
A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A.; Kino T.; Combe H.; Lecomte P.; Chrousos G.P.;
J. Clin. Endocrinol. Metab. 87:2658-2667(2002)
Cited for: VARIANT GCCR MET-747; ALTERED INTERACTION WITH THE COACTIVATOR NCOA2;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.